drugset

drugset / Trial / NCT02446223

Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

NCT02446223 ↗

Phase 4 Completed 21 enrolled Goldman, Butterwick, Fitzpatrick and Groff LEO Pharma · collab

NaSingle-groupOpen-labelTreatment

Summary

Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

Timeline

Start: 2015-01
Primary completion: 2016-09
Completion: 2016-09

Publications

Wu DC, Guiha I, Goldman MP. A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest. J Clin Aesthet Dermatol. 2017 Aug;10(8):31-36. Epub 2017 Aug 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ingenol mebutate	Small molecule	0.015 %	Topical

Indications